Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meenu Wadhwa

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 14, 2021
Therapeutic use of specific tumour necrosis factor inhibitors in inflammatory diseases including COVID-19Serena Patel, Meenu Wadhwa
Bioanalysis|November 19, 2010
Unwanted immunogenicity: lessons learned and future challengesMeenu Wadhwa, Robin Thorpe
Idrugs : the Investigational Drugs Journal|July 7, 2009
The challenges of immunogenicity in developing biosimilar productsMeenu Wadhwa, Robin Thorpe
Journal of Immunotoxicology|October 30, 2008
Strategies and assays for the assessment of unwanted immunogenicityMeenu Wadhwa, Robin Thorpe
Bioanalysis|November 8, 2019
Harmonization and standardization of immunogenicity assessment of biotherapeutic productsMeenu Wadhwa, Robin Thorpe
Expert Review of Clinical Immunology|June 6, 2014
Detection of anti-cytokine antibodies and their clinical relevanceAnthony Meager, Meenu Wadhwa
Biologicals : Journal of the International Association of Biological Standardization|September 2, 2011
Intended use of reference products & WHO International Standards/Reference Reagents in the development of similar biological products (biosimilars)Robin Thorpe, Meenu Wadhwa
Bioanalysis|February 22, 2013
European perspective on biosimilarsMeenu Wadhwa, Robin Thorpe
Cytokine|August 12, 2019
WHO International Standards and reference preparations for cytokines and growth factorsAmanda Proudfoot, Meenu Wadhwa
Thrombosis and Haemostasis|May 2, 2008
Haematopoietic growth factors and their therapeutic useMeenu Wadhwa, Robin Thorpe
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 14, 2021
Therapeutic use of specific tumour necrosis factor inhibitors in inflammatory diseases including COVID-19Serena Patel, Meenu Wadhwa
Bioanalysis|November 19, 2010
Unwanted immunogenicity: lessons learned and future challengesMeenu Wadhwa, Robin Thorpe
Idrugs : the Investigational Drugs Journal|July 7, 2009
The challenges of immunogenicity in developing biosimilar productsMeenu Wadhwa, Robin Thorpe
Journal of Immunotoxicology|October 30, 2008
Strategies and assays for the assessment of unwanted immunogenicityMeenu Wadhwa, Robin Thorpe
Bioanalysis|November 8, 2019
Harmonization and standardization of immunogenicity assessment of biotherapeutic productsMeenu Wadhwa, Robin Thorpe
Expert Review of Clinical Immunology|June 6, 2014
Detection of anti-cytokine antibodies and their clinical relevanceAnthony Meager, Meenu Wadhwa
Biologicals : Journal of the International Association of Biological Standardization|September 2, 2011
Intended use of reference products & WHO International Standards/Reference Reagents in the development of similar biological products (biosimilars)Robin Thorpe, Meenu Wadhwa
Bioanalysis|February 22, 2013
European perspective on biosimilarsMeenu Wadhwa, Robin Thorpe
Cytokine|August 12, 2019
WHO International Standards and reference preparations for cytokines and growth factorsAmanda Proudfoot, Meenu Wadhwa
Thrombosis and Haemostasis|May 2, 2008
Haematopoietic growth factors and their therapeutic useMeenu Wadhwa, Robin Thorpe
Pageof 9